InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Leyman Barbara. Director active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 1 filings have been published. History available since 8 July 2025. The latest transaction was disclosed on 8 July 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration